Jci_page_head_homepage_01 Jci_page_head_homepage_02
Yasunobu Miyake, Kenichi Asano, Hitomi Kaise, Miho Uemura, Manabu Nakayama, Masato Tanaka
Published in Volume 117, Issue 8
J Clin Invest. 2007; 117(8):2268–2278 doi:10.1172/JCI31990
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Medium
Figure 8
Aberrant engulfment of apoptotic cells by CD11b+ DCs in MZM-depleted mice.

We intraperitoneally injected 10 μg/kg of DT into wild-type (+/+) or CD169-DTR (+/CD169DTR) mice. Four days after DT treatment, CMFDA-labeled apoptotic W3/MOG-L cells (2 × 107 cells) were intravenously injected, and the spleens were obtained at the indicated times after injection. Splenic DCs were enriched by cell sorting with anti-CD11c microbeads and stained with CD11c-PE, CD8α-PE, or CD11b-PE. PE and CMFDA double-positive cells were considered to have engulfed the injected apoptotic cells. (A) Kinetics of apoptotic cell engulfment by DC subsets. (B) Engulfment of apoptotic cells by DC subsets 1 hour after injection. These results are representative of 3 independent experiments, and mean values are shown with SD. *P < 0.01. (C) Antigen-presentation activity of DC subsets. We intravenously injected W3/OVA cells (2 × 107 cells) into wild-type (+/+) and DT-treated CD169-DTR (+/CD169DTR) mice, and spleen was obtained 3 hours after injection. CD11c+ DCs were further separated into CD8α+ DCs and CD11b+ DCs by the cell sorter. Indicated number of DC subsets was cocultured with OT-II cells (2 × 105 cells) for 60 hours. T cell proliferation was quantified based on [3H] thymidine uptake in the last 12 hours of the culture. These results are representative of 2 independent experiments, and mean values are shown with SD.